Enrico Cipro Vanni Buys 40,000 Shares of Advanced Oncotherapy PLC (AVO) Stock
Advanced Oncotherapy PLC (LON:AVO) insider Enrico Cipro Vanni bought 40,000 shares of the company’s stock in a transaction on Thursday, January 11th. The shares were acquired at an average price of GBX 55 ($0.75) per share, with a total value of £22,000 ($29,834.55).
Shares of Advanced Oncotherapy PLC (LON:AVO) traded up GBX 1 ($0.01) during trading on Friday, hitting GBX 54.50 ($0.74). 78,169 shares of the company’s stock traded hands, compared to its average volume of 321,124. The company has a market cap of $127.30 and a PE ratio of -340.63. Advanced Oncotherapy PLC has a 52 week low of GBX 9.75 ($0.13) and a 52 week high of GBX 87 ($1.18).
About Advanced Oncotherapy
Advanced Oncotherapy Plc is focused on providing radiotherapy systems for cancer treatment through the use of a proton therapy technology. The Company is engaged in development and then building of the Linac Image Guided Hadron Technology (LIGHT) proton beam cancer therapy device and management of healthcare related property.
Receive News & Ratings for Advanced Oncotherapy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Advanced Oncotherapy and related companies with MarketBeat.com's FREE daily email newsletter.